Replies to post #148053 on Biotech Values

[mcbio]

now we are mixing two different BACE programs.

One is MRK/SGP licensed from LGND/PCOP

One is AZN licensed from Astex/Supergen/ASTX

I know that. I was just showing that whereas LGND is likely only due mid-single-digit at best royalties on their BACE inhibitor, ASTX is likely due much better double-digit terms on their own BACE inhibitor.